| Bharat Dhirajlal Parekh, MD | |
|
6900 Pecos Rd, North Las Vegas, NV 89086-4400 | |
| (702) 791-9090 | |
| (702) 224-6907 |
| Full Name | Bharat Dhirajlal Parekh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 6900 Pecos Rd, North Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841212586 | NPI | - | NPPES |
| 210642 | Other | MD | MAMSI |
| 4756 | Other | MD | ELDER HEALTH |
| 779431200 | Medicaid | MD | |
| E1470001 | Other | MD | CARE FIRST BLUE CHOICE |
| 454532 | Other | MD | AETNA HEALTH CARE |
| 6727 | Other | MD | CARE FIRST BCBS |
| E1470001 | Other | MD | FEDERAL BLUE CROSS/SHIELD |
| 409111281 | Other | MD | PALMETTA/RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | D0018424 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bharat Dhirajlal Parekh, MD 6900 Pecos Rd, North Las Vegas, NV 89086-4400 Ph: (702) 791-9090 | Bharat Dhirajlal Parekh, MD 6900 Pecos Rd, North Las Vegas, NV 89086-4400 Ph: (702) 791-9090 |
News Archive
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.
Sosei Group Corporation, a biopharmaceutical company, today announces the assignment of the drug discovery programme, SD281 and its analogues, to Biocopea Limited, a UK biotechnology company and subsidiary of PepTcell Limited. These compounds, based on a metabolite of a well-known drug, were shown by Sosei to have pronounced anti-inflammatory properties.
GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).
Patients who suffer from Neurologic Post Treatment Lyme disease and those with the Chronic Fatigue Syndrome report similar symptoms. However unique proteins discovered in spinal fluid can distinguish those two groups from one another and also from people in normal health, according to new research conducted by a team led by Steven E. Schutzer, MD, of the University of Medicine and Dentistry of New Jersey - New Jersey Medical School, and Richard D. Smith, Ph.D., of Pacific Northwest National Laboratory.
› Verified 9 days ago
Dr. Ko Ko Latt, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Yun Namkung, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Dr. Diane Hweelan Mak, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Dr. Cameron Charlow, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
J Cal Noorda, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1302 W Craig Rd, North Las Vegas, NV 89032 Phone: 702-657-9555 Fax: 702-657-9040 | |
Brooke Hill, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 714-864-0221 | |
Daniela Kin, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 |